Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?

Nature Clinical Practice Oncology volume 3, pages 480–481 (2006)Cite this article

boxed-textKemeny N et al. (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24: 1395–1403

Relevant phase II triple combination studies with biological agents should clarify the role of the hepatic arterial infusion of fluorodeoxyuridine in hepatic metastatic colorectal cancer

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kerr DJ et al. (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361: 368–373

    Article  CAS  Google Scholar 

  2. Hurwitz H et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335–2342

    Article  CAS  Google Scholar 

  3. Grothey A et al. (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-FA, irinotecan and oxaliplatin in the course of treatment. J Clin Oncol 22: 1209–1214

    Article  CAS  Google Scholar 

  4. Kemeny N et al. (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23: 4888–4896

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Clinical Pharmacology and Cancer Therapeutics and Director of the National Translational Research Network in the Department of Clinical Pharmacology at the Radcliffe Infirmary, Oxford, UK

    David J Kerr

Authors
  1. David J Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J Kerr.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kerr, D. Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?. Nat Rev Clin Oncol 3, 480–481 (2006). https://doi.org/10.1038/ncponc0566

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0566

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing